Inventor · disambiguated record
Buelent Kocer
Also filed as: KOCER BUELENT
16 granted patents·9 pending applications·76 citations·filing 2011–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0196US12209091B2Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancersHOFFMANN LA ROCHE·Filed 2020·Granted Jan 28, 2025·7 cites·30 claims
- 0294US11420961B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Aug 23, 2022·6 cites·19 claims
- 0394US9447086B26-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2013·Granted Sep 20, 2016·34 cites·5 claims
- 0492US11802133B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Granted Oct 31, 2023·2 cites·10 claims
- 0592US11608347B2Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Mar 21, 2023·4 cites·30 claims
- 0692US11390610B2Piperazine derivatives as MAGL inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jul 19, 2022·6 cites·38 claims
- 0781US12281124B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2023·Granted Apr 22, 2025·0 cites·20 claims
- 0880US9266904B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2014·Granted Feb 23, 2016·5 cites·23 claims
- 0979US9758530B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Sep 12, 2017·3 cites·14 claims
- 1079US8940741B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2013·Granted Jan 27, 2015·4 cites·19 claims
- 1176US8481540B2Inhibitors of bruton's tyrosine kinaseBERTHEL STEVEN JOSEPH·Filed 2011·Granted Jul 9, 2013·4 cites·17 claims
- 1270US2023183224A1Bezoxazine derivatives useful as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1369US2024400556A1Amidopyrimidone derivativesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1467US9693997B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Jul 4, 2017·1 cites·19 claims
- 1566US2023117324A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1665US2020308190A1Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1764US2023227449A1Amidopyrimidone derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1858US2021107920A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1958US2023382911A1Pyrazoleamide derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2057US2020308158A1Bezoxazine derivatives useful as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2152US10435407B2Triaza-spirodecanones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Oct 8, 2019·0 cites·23 claims
- 2250US9540345B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Jan 10, 2017·0 cites·2 claims
- 2349US10239876B2Triaza-spirodecanones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2017·Granted Mar 26, 2019·0 cites·25 claims
- 2442US10618897B2Spiroindolinones as DDR1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Apr 14, 2020·0 cites·34 claims
- 2542US2017081312A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Buelent Kocer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →